FG-2101

N/A

Report date: 2024/04/30 13:52:31
NME

Base Information

Drug NameFG-2101
Drug Alias NameFG-2101FG2101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsLung DiseasesUrinary Tract InfectionsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlacksmith Medicines Inc
Inactive CompaniesN/A
Active IndicationsLung DiseasesUrinary Tract InfectionsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A